Cancilico
Health
· Headquartered in Germany 🇩🇪
Track Cancilico
— get Health deals in free daily digest
Overview
Cancilico, a Dresden-based AI diagnostics startup focused on blood cancers, has raised €2.5 million in a seed round to expand commercialization and pursue regulatory pathways for its bone marrow analysis software, Myeloaid. The financing was led by a syndicate including High-Tech Gründerfonds (HTGF), TGFS – Technologiegründerfonds Sachsen, Gedad GmbH, and ROI Verwaltungsgesellschaft.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
Investors: High-Tech Gründerfonds (HTGF), TGFS – Technologiegründerfonds Sachsen, Gedad GmbH, ROI Verwaltungsgesellschaft
Cancilico, a Dresden-based AI diagnostics startup focused on blood cancers, has raised €2.5 million in a seed round to expand commercialization and pursue regulatory pathways for its bone marrow analysis software, Myeloaid. The financing was led by a syndicate including High-Tech Gründerfonds (HTGF), TGFS – Technologiegründerfonds Sachsen, Gedad GmbH, and ROI Verwaltungsgesellschaft.